nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—Ocular toxicity—Carmustine—malignant glioma	0.0325	0.101	CcSEcCtD
Fluorouracil—CYP1A2—Carmustine—malignant glioma	0.0232	1	CbGbCtD
Fluorouracil—Fibrosis—Carmustine—malignant glioma	0.0154	0.0478	CcSEcCtD
Fluorouracil—UPP2—central nervous system—malignant glioma	0.0115	0.0447	CbGeAlD
Fluorouracil—TYMP—endothelium—malignant glioma	0.0111	0.043	CbGeAlD
Fluorouracil—TYMP—blood vessel—malignant glioma	0.0102	0.0397	CbGeAlD
Fluorouracil—MTHFR—blood vessel—malignant glioma	0.0096	0.0373	CbGeAlD
Fluorouracil—Myelosuppression—Carmustine—malignant glioma	0.00938	0.0291	CcSEcCtD
Fluorouracil—UPP2—brain—malignant glioma	0.00913	0.0355	CbGeAlD
Fluorouracil—Myelosuppression—Temozolomide—malignant glioma	0.00906	0.0282	CcSEcCtD
Fluorouracil—UMPS—medulla oblongata—malignant glioma	0.00902	0.035	CbGeAlD
Fluorouracil—UPP1—medulla oblongata—malignant glioma	0.00827	0.0321	CbGeAlD
Fluorouracil—UMPS—midbrain—malignant glioma	0.00825	0.032	CbGeAlD
Fluorouracil—PPAT—retina—malignant glioma	0.00804	0.0312	CbGeAlD
Fluorouracil—UPP1—midbrain—malignant glioma	0.00756	0.0294	CbGeAlD
Fluorouracil—Skin hyperpigmentation—Carmustine—malignant glioma	0.00739	0.023	CcSEcCtD
Fluorouracil—UPP1—spinal cord—malignant glioma	0.00738	0.0287	CbGeAlD
Fluorouracil—Febrile neutropenia—Carmustine—malignant glioma	0.00731	0.0227	CcSEcCtD
Fluorouracil—Febrile neutropenia—Temozolomide—malignant glioma	0.00706	0.0219	CcSEcCtD
Fluorouracil—Encephalopathy—Carmustine—malignant glioma	0.00685	0.0213	CcSEcCtD
Fluorouracil—UMPS—central nervous system—malignant glioma	0.00653	0.0254	CbGeAlD
Fluorouracil—UMPS—cerebellum—malignant glioma	0.00638	0.0248	CbGeAlD
Fluorouracil—UPP1—cerebellum—malignant glioma	0.00585	0.0227	CbGeAlD
Fluorouracil—PPAT—medulla oblongata—malignant glioma	0.00581	0.0226	CbGeAlD
Fluorouracil—Necrosis—Carmustine—malignant glioma	0.0056	0.0174	CcSEcCtD
Fluorouracil—PPAT—midbrain—malignant glioma	0.00531	0.0206	CbGeAlD
Fluorouracil—PPAT—spinal cord—malignant glioma	0.00518	0.0201	CbGeAlD
Fluorouracil—UMPS—brain—malignant glioma	0.00518	0.0201	CbGeAlD
Fluorouracil—Speech disorder—Carmustine—malignant glioma	0.00511	0.0159	CcSEcCtD
Fluorouracil—Extravasation—Carmustine—malignant glioma	0.00504	0.0157	CcSEcCtD
Fluorouracil—Speech disorder—Temozolomide—malignant glioma	0.00494	0.0154	CcSEcCtD
Fluorouracil—UPP1—brain—malignant glioma	0.00475	0.0185	CbGeAlD
Fluorouracil—Leukocytosis—Carmustine—malignant glioma	0.00468	0.0145	CcSEcCtD
Fluorouracil—MTHFR—telencephalon—malignant glioma	0.00466	0.0181	CbGeAlD
Fluorouracil—Herpes simplex—Temozolomide—malignant glioma	0.00461	0.0143	CcSEcCtD
Fluorouracil—ABCC5—retina—malignant glioma	0.00451	0.0175	CbGeAlD
Fluorouracil—TYMS—telencephalon—malignant glioma	0.00425	0.0165	CbGeAlD
Fluorouracil—PPAT—central nervous system—malignant glioma	0.00421	0.0163	CbGeAlD
Fluorouracil—ABCC5—telencephalon—malignant glioma	0.00415	0.0161	CbGeAlD
Fluorouracil—PPAT—cerebellum—malignant glioma	0.00411	0.016	CbGeAlD
Fluorouracil—Coma—Carmustine—malignant glioma	0.00402	0.0125	CcSEcCtD
Fluorouracil—TYMP—medulla oblongata—malignant glioma	0.00389	0.0151	CbGeAlD
Fluorouracil—DPYD—brain—malignant glioma	0.00386	0.015	CbGeAlD
Fluorouracil—Sepsis—Carmustine—malignant glioma	0.00381	0.0119	CcSEcCtD
Fluorouracil—SLC29A1—telencephalon—malignant glioma	0.00381	0.0148	CbGeAlD
Fluorouracil—Thrombophlebitis—Carmustine—malignant glioma	0.00369	0.0115	CcSEcCtD
Fluorouracil—Swelling—Carmustine—malignant glioma	0.00362	0.0112	CcSEcCtD
Fluorouracil—Thrombophlebitis—Temozolomide—malignant glioma	0.00356	0.0111	CcSEcCtD
Fluorouracil—TYMP—midbrain—malignant glioma	0.00356	0.0138	CbGeAlD
Fluorouracil—TYMP—spinal cord—malignant glioma	0.00347	0.0135	CbGeAlD
Fluorouracil—Amnesia—Carmustine—malignant glioma	0.0034	0.0106	CcSEcCtD
Fluorouracil—PPAT—brain—malignant glioma	0.00334	0.013	CbGeAlD
Fluorouracil—Amnesia—Temozolomide—malignant glioma	0.00328	0.0102	CcSEcCtD
Fluorouracil—ABCC5—medulla oblongata—malignant glioma	0.00326	0.0127	CbGeAlD
Fluorouracil—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00319	0.00992	CcSEcCtD
Fluorouracil—TYMS—midbrain—malignant glioma	0.00305	0.0119	CbGeAlD
Fluorouracil—Ataxia—Carmustine—malignant glioma	0.003	0.00933	CcSEcCtD
Fluorouracil—ABCC5—midbrain—malignant glioma	0.00298	0.0116	CbGeAlD
Fluorouracil—Ataxia—Temozolomide—malignant glioma	0.0029	0.00901	CcSEcCtD
Fluorouracil—Dry skin—Temozolomide—malignant glioma	0.00283	0.00879	CcSEcCtD
Fluorouracil—TYMP—central nervous system—malignant glioma	0.00282	0.0109	CbGeAlD
Fluorouracil—Muscular weakness—Carmustine—malignant glioma	0.00281	0.00875	CcSEcCtD
Fluorouracil—Dysphagia—Carmustine—malignant glioma	0.00276	0.00857	CcSEcCtD
Fluorouracil—TYMP—cerebellum—malignant glioma	0.00275	0.0107	CbGeAlD
Fluorouracil—Muscular weakness—Temozolomide—malignant glioma	0.00272	0.00845	CcSEcCtD
Fluorouracil—Dysphagia—Temozolomide—malignant glioma	0.00267	0.00828	CcSEcCtD
Fluorouracil—MTHFR—central nervous system—malignant glioma	0.00265	0.0103	CbGeAlD
Fluorouracil—Pancytopenia—Carmustine—malignant glioma	0.00262	0.00814	CcSEcCtD
Fluorouracil—MTHFR—cerebellum—malignant glioma	0.00259	0.01	CbGeAlD
Fluorouracil—Pancytopenia—Temozolomide—malignant glioma	0.00253	0.00787	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00248	0.0077	CcSEcCtD
Fluorouracil—Pneumonia—Carmustine—malignant glioma	0.00247	0.00769	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Temozolomide—malignant glioma	0.00243	0.00756	CcSEcCtD
Fluorouracil—TYMS—central nervous system—malignant glioma	0.00242	0.00938	CbGeAlD
Fluorouracil—Neuropathy peripheral—Carmustine—malignant glioma	0.00241	0.00749	CcSEcCtD
Fluorouracil—Stomatitis—Carmustine—malignant glioma	0.0024	0.00745	CcSEcCtD
Fluorouracil—Urinary tract infection—Carmustine—malignant glioma	0.00239	0.00743	CcSEcCtD
Fluorouracil—Pneumonia—Temozolomide—malignant glioma	0.00239	0.00743	CcSEcCtD
Fluorouracil—Infestation NOS—Temozolomide—malignant glioma	0.00238	0.00739	CcSEcCtD
Fluorouracil—Infestation—Temozolomide—malignant glioma	0.00238	0.00739	CcSEcCtD
Fluorouracil—TYMS—cerebellum—malignant glioma	0.00236	0.00917	CbGeAlD
Fluorouracil—Neuropathy peripheral—Temozolomide—malignant glioma	0.00233	0.00724	CcSEcCtD
Fluorouracil—Stomatitis—Temozolomide—malignant glioma	0.00232	0.0072	CcSEcCtD
Fluorouracil—Urinary tract infection—Temozolomide—malignant glioma	0.00231	0.00718	CcSEcCtD
Fluorouracil—ABCC5—cerebellum—malignant glioma	0.00231	0.00896	CbGeAlD
Fluorouracil—TYMP—brain—malignant glioma	0.00224	0.00868	CbGeAlD
Fluorouracil—Sinusitis—Temozolomide—malignant glioma	0.00223	0.00693	CcSEcCtD
Fluorouracil—SLC22A7—brain—malignant glioma	0.00223	0.00866	CbGeAlD
Fluorouracil—Haemoglobin—Carmustine—malignant glioma	0.00222	0.0069	CcSEcCtD
Fluorouracil—Haemorrhage—Carmustine—malignant glioma	0.00221	0.00686	CcSEcCtD
Fluorouracil—Hypoaesthesia—Carmustine—malignant glioma	0.0022	0.00683	CcSEcCtD
Fluorouracil—SLC29A1—central nervous system—malignant glioma	0.00217	0.00841	CbGeAlD
Fluorouracil—Haemoglobin—Temozolomide—malignant glioma	0.00214	0.00666	CcSEcCtD
Fluorouracil—Haemorrhage—Temozolomide—malignant glioma	0.00213	0.00663	CcSEcCtD
Fluorouracil—Hypoaesthesia—Temozolomide—malignant glioma	0.00212	0.0066	CcSEcCtD
Fluorouracil—Pharyngitis—Temozolomide—malignant glioma	0.00212	0.00658	CcSEcCtD
Fluorouracil—SLC29A1—cerebellum—malignant glioma	0.00212	0.00822	CbGeAlD
Fluorouracil—MTHFR—brain—malignant glioma	0.0021	0.00816	CbGeAlD
Fluorouracil—CYP2A6—cerebellum—malignant glioma	0.00207	0.00803	CbGeAlD
Fluorouracil—ABCG2—telencephalon—malignant glioma	0.00203	0.00789	CbGeAlD
Fluorouracil—ABCC3—central nervous system—malignant glioma	0.00198	0.0077	CbGeAlD
Fluorouracil—Arrhythmia—Carmustine—malignant glioma	0.00197	0.00613	CcSEcCtD
Fluorouracil—Alopecia—Carmustine—malignant glioma	0.00195	0.00606	CcSEcCtD
Fluorouracil—Erythema—Carmustine—malignant glioma	0.00192	0.00597	CcSEcCtD
Fluorouracil—TYMS—brain—malignant glioma	0.00192	0.00745	CbGeAlD
Fluorouracil—Alopecia—Temozolomide—malignant glioma	0.00189	0.00586	CcSEcCtD
Fluorouracil—ABCC5—brain—malignant glioma	0.00187	0.00728	CbGeAlD
Fluorouracil—Erythema—Temozolomide—malignant glioma	0.00186	0.00577	CcSEcCtD
Fluorouracil—Vision blurred—Carmustine—malignant glioma	0.00181	0.00563	CcSEcCtD
Fluorouracil—Anaemia—Carmustine—malignant glioma	0.00178	0.00552	CcSEcCtD
Fluorouracil—Vision blurred—Temozolomide—malignant glioma	0.00175	0.00544	CcSEcCtD
Fluorouracil—Leukopenia—Carmustine—malignant glioma	0.00172	0.00535	CcSEcCtD
Fluorouracil—SLC29A1—brain—malignant glioma	0.00172	0.00668	CbGeAlD
Fluorouracil—Anaemia—Temozolomide—malignant glioma	0.00172	0.00534	CcSEcCtD
Fluorouracil—CYP2A6—brain—malignant glioma	0.00168	0.00652	CbGeAlD
Fluorouracil—Convulsion—Carmustine—malignant glioma	0.00167	0.00518	CcSEcCtD
Fluorouracil—Leukopenia—Temozolomide—malignant glioma	0.00166	0.00517	CcSEcCtD
Fluorouracil—Chest pain—Carmustine—malignant glioma	0.00164	0.00509	CcSEcCtD
Fluorouracil—Myalgia—Carmustine—malignant glioma	0.00164	0.00509	CcSEcCtD
Fluorouracil—ABCC4—central nervous system—malignant glioma	0.00164	0.00635	CbGeAlD
Fluorouracil—Convulsion—Temozolomide—malignant glioma	0.00161	0.005	CcSEcCtD
Fluorouracil—ABCG2—medulla oblongata—malignant glioma	0.0016	0.0062	CbGeAlD
Fluorouracil—Confusional state—Carmustine—malignant glioma	0.00158	0.00492	CcSEcCtD
Fluorouracil—Myalgia—Temozolomide—malignant glioma	0.00158	0.00491	CcSEcCtD
Fluorouracil—ABCC3—brain—malignant glioma	0.00157	0.00611	CbGeAlD
Fluorouracil—Oedema—Carmustine—malignant glioma	0.00157	0.00487	CcSEcCtD
Fluorouracil—Discomfort—Temozolomide—malignant glioma	0.00156	0.00486	CcSEcCtD
Fluorouracil—Infection—Carmustine—malignant glioma	0.00156	0.00484	CcSEcCtD
Fluorouracil—Thrombocytopenia—Carmustine—malignant glioma	0.00154	0.00477	CcSEcCtD
Fluorouracil—Tachycardia—Carmustine—malignant glioma	0.00153	0.00476	CcSEcCtD
Fluorouracil—Confusional state—Temozolomide—malignant glioma	0.00153	0.00475	CcSEcCtD
Fluorouracil—Anaphylactic shock—Temozolomide—malignant glioma	0.00152	0.00471	CcSEcCtD
Fluorouracil—Oedema—Temozolomide—malignant glioma	0.00152	0.00471	CcSEcCtD
Fluorouracil—Infection—Temozolomide—malignant glioma	0.00151	0.00468	CcSEcCtD
Fluorouracil—Anorexia—Carmustine—malignant glioma	0.0015	0.00465	CcSEcCtD
Fluorouracil—Nervous system disorder—Temozolomide—malignant glioma	0.00149	0.00462	CcSEcCtD
Fluorouracil—Thrombocytopenia—Temozolomide—malignant glioma	0.00148	0.00461	CcSEcCtD
Fluorouracil—Hypotension—Carmustine—malignant glioma	0.00147	0.00456	CcSEcCtD
Fluorouracil—ABCG2—midbrain—malignant glioma	0.00146	0.00567	CbGeAlD
Fluorouracil—Anorexia—Temozolomide—malignant glioma	0.00144	0.00449	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00143	0.00444	CcSEcCtD
Fluorouracil—ABCG2—spinal cord—malignant glioma	0.00142	0.00553	CbGeAlD
Fluorouracil—Insomnia—Carmustine—malignant glioma	0.00142	0.00441	CcSEcCtD
Fluorouracil—Paraesthesia—Carmustine—malignant glioma	0.00141	0.00438	CcSEcCtD
Fluorouracil—Dyspnoea—Carmustine—malignant glioma	0.0014	0.00435	CcSEcCtD
Fluorouracil—Somnolence—Carmustine—malignant glioma	0.00139	0.00433	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00138	0.00429	CcSEcCtD
Fluorouracil—Insomnia—Temozolomide—malignant glioma	0.00137	0.00426	CcSEcCtD
Fluorouracil—Decreased appetite—Carmustine—malignant glioma	0.00136	0.00424	CcSEcCtD
Fluorouracil—Paraesthesia—Temozolomide—malignant glioma	0.00136	0.00423	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Carmustine—malignant glioma	0.00135	0.00421	CcSEcCtD
Fluorouracil—Dyspnoea—Temozolomide—malignant glioma	0.00135	0.0042	CcSEcCtD
Fluorouracil—Somnolence—Temozolomide—malignant glioma	0.00135	0.00419	CcSEcCtD
Fluorouracil—ALB—brain—malignant glioma	0.00134	0.00521	CbGeAlD
Fluorouracil—Pain—Carmustine—malignant glioma	0.00134	0.00417	CcSEcCtD
Fluorouracil—Dyspepsia—Temozolomide—malignant glioma	0.00133	0.00415	CcSEcCtD
Fluorouracil—Decreased appetite—Temozolomide—malignant glioma	0.00132	0.0041	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00131	0.00407	CcSEcCtD
Fluorouracil—ABCC4—brain—malignant glioma	0.0013	0.00504	CbGeAlD
Fluorouracil—Pain—Temozolomide—malignant glioma	0.0013	0.00403	CcSEcCtD
Fluorouracil—Feeling abnormal—Carmustine—malignant glioma	0.00129	0.00402	CcSEcCtD
Fluorouracil—Feeling abnormal—Temozolomide—malignant glioma	0.00125	0.00388	CcSEcCtD
Fluorouracil—Body temperature increased—Carmustine—malignant glioma	0.00124	0.00385	CcSEcCtD
Fluorouracil—Urticaria—Temozolomide—malignant glioma	0.0012	0.00374	CcSEcCtD
Fluorouracil—Body temperature increased—Temozolomide—malignant glioma	0.0012	0.00372	CcSEcCtD
Fluorouracil—Hypersensitivity—Carmustine—malignant glioma	0.00116	0.00359	CcSEcCtD
Fluorouracil—ABCG2—cerebellum—malignant glioma	0.00113	0.00438	CbGeAlD
Fluorouracil—Hypersensitivity—Temozolomide—malignant glioma	0.00112	0.00347	CcSEcCtD
Fluorouracil—Diarrhoea—Carmustine—malignant glioma	0.00107	0.00334	CcSEcCtD
Fluorouracil—Pruritus—Temozolomide—malignant glioma	0.00107	0.00333	CcSEcCtD
Fluorouracil—Dizziness—Carmustine—malignant glioma	0.00104	0.00322	CcSEcCtD
Fluorouracil—Diarrhoea—Temozolomide—malignant glioma	0.00104	0.00322	CcSEcCtD
Fluorouracil—Dizziness—Temozolomide—malignant glioma	0.001	0.00312	CcSEcCtD
Fluorouracil—Vomiting—Carmustine—malignant glioma	0.000997	0.0031	CcSEcCtD
Fluorouracil—Rash—Carmustine—malignant glioma	0.000989	0.00307	CcSEcCtD
Fluorouracil—Dermatitis—Carmustine—malignant glioma	0.000988	0.00307	CcSEcCtD
Fluorouracil—Headache—Carmustine—malignant glioma	0.000983	0.00305	CcSEcCtD
Fluorouracil—Vomiting—Temozolomide—malignant glioma	0.000964	0.003	CcSEcCtD
Fluorouracil—Rash—Temozolomide—malignant glioma	0.000956	0.00297	CcSEcCtD
Fluorouracil—Dermatitis—Temozolomide—malignant glioma	0.000955	0.00297	CcSEcCtD
Fluorouracil—Headache—Temozolomide—malignant glioma	0.00095	0.00295	CcSEcCtD
Fluorouracil—CYP2C8—brain—malignant glioma	0.000943	0.00366	CbGeAlD
Fluorouracil—Nausea—Carmustine—malignant glioma	0.000932	0.0029	CcSEcCtD
Fluorouracil—ABCG2—brain—malignant glioma	0.000917	0.00356	CbGeAlD
Fluorouracil—Nausea—Temozolomide—malignant glioma	0.0009	0.0028	CcSEcCtD
Fluorouracil—ALB—Hemostasis—PTK2—malignant glioma	6.09e-05	0.000153	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—ERBB2—malignant glioma	6.08e-05	0.000153	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.06e-05	0.000153	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	6.03e-05	0.000152	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CAT—malignant glioma	6e-05	0.000151	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CB—malignant glioma	6e-05	0.000151	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CD—malignant glioma	6e-05	0.000151	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTGS2—malignant glioma	5.95e-05	0.00015	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VEGFA—malignant glioma	5.84e-05	0.000147	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—BCAN—malignant glioma	5.83e-05	0.000147	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—IDH2—malignant glioma	5.78e-05	0.000145	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CD—malignant glioma	5.77e-05	0.000145	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS1—malignant glioma	5.75e-05	0.000145	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—IDH2—malignant glioma	5.74e-05	0.000145	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—FGF2—malignant glioma	5.74e-05	0.000144	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CG—malignant glioma	5.71e-05	0.000144	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—NCOR1—malignant glioma	5.67e-05	0.000143	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CAV1—malignant glioma	5.58e-05	0.00014	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTT1—malignant glioma	5.58e-05	0.00014	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.57e-05	0.00014	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PPARG—malignant glioma	5.51e-05	0.000139	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.45e-05	0.000137	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP2B6—malignant glioma	5.43e-05	0.000137	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.42e-05	0.000136	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP2B6—malignant glioma	5.4e-05	0.000136	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MDM2—malignant glioma	5.37e-05	0.000135	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—RAF1—malignant glioma	5.35e-05	0.000135	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—malignant glioma	5.35e-05	0.000135	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—BCHE—malignant glioma	5.35e-05	0.000135	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—AKT1—malignant glioma	5.33e-05	0.000134	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—AKT1—malignant glioma	5.33e-05	0.000134	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ASMT—malignant glioma	5.3e-05	0.000133	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—ERBB2—malignant glioma	5.3e-05	0.000133	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SLC5A5—malignant glioma	5.28e-05	0.000133	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CB—malignant glioma	5.23e-05	0.000131	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS1—malignant glioma	5.23e-05	0.000131	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTEN—malignant glioma	5.19e-05	0.00013	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.18e-05	0.00013	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTGS2—malignant glioma	5.18e-05	0.00013	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	5.13e-05	0.000129	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PDGFB—malignant glioma	5.12e-05	0.000129	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CG—malignant glioma	5.09e-05	0.000128	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CB—malignant glioma	5.03e-05	0.000126	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CD—malignant glioma	5.02e-05	0.000126	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—BCAN—malignant glioma	4.99e-05	0.000125	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTGS2—malignant glioma	4.98e-05	0.000125	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—IDH1—malignant glioma	4.97e-05	0.000125	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—KRAS—malignant glioma	4.96e-05	0.000125	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—IDH1—malignant glioma	4.94e-05	0.000124	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PPARG—malignant glioma	4.91e-05	0.000123	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	4.86e-05	0.000122	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—BCHE—malignant glioma	4.86e-05	0.000122	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—CAV1—malignant glioma	4.85e-05	0.000122	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SPHK1—malignant glioma	4.81e-05	0.000121	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SLC5A5—malignant glioma	4.8e-05	0.000121	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SPHK1—malignant glioma	4.78e-05	0.00012	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP2C18—malignant glioma	4.71e-05	0.000118	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—IDH2—malignant glioma	4.7e-05	0.000118	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP2C18—malignant glioma	4.68e-05	0.000118	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PIK3CA—malignant glioma	4.64e-05	0.000117	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—STAT3—malignant glioma	4.64e-05	0.000117	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CAV1—malignant glioma	4.62e-05	0.000116	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—F2—malignant glioma	4.62e-05	0.000116	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—FN1—malignant glioma	4.62e-05	0.000116	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—PIK3CA—malignant glioma	4.56e-05	0.000115	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTEN—malignant glioma	4.52e-05	0.000114	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CD—malignant glioma	4.47e-05	0.000112	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.44e-05	0.000112	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.43e-05	0.000112	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP2B6—malignant glioma	4.42e-05	0.000111	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CG—malignant glioma	4.42e-05	0.000111	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.42e-05	0.000111	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.42e-05	0.000111	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—malignant glioma	4.41e-05	0.000111	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CB—malignant glioma	4.38e-05	0.00011	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—EGF—malignant glioma	4.37e-05	0.00011	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTEN—malignant glioma	4.34e-05	0.000109	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PTPN11—malignant glioma	4.34e-05	0.000109	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTGS2—malignant glioma	4.34e-05	0.000109	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MYC—malignant glioma	4.31e-05	0.000108	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GSTP1—malignant glioma	4.25e-05	0.000107	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—EGFR—malignant glioma	4.22e-05	0.000106	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CG—malignant glioma	4.21e-05	0.000106	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CAT—malignant glioma	4.14e-05	0.000104	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PPARG—malignant glioma	4.06e-05	0.000102	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.05e-05	0.000102	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—IDH1—malignant glioma	4.04e-05	0.000102	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT2—malignant glioma	4.04e-05	0.000102	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—STAT3—malignant glioma	4.04e-05	0.000102	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.02e-05	0.000101	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—IDH2—malignant glioma	4.02e-05	0.000101	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	4e-05	0.000101	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KRAS—malignant glioma	3.98e-05	0.0001	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SPHK1—malignant glioma	3.91e-05	9.84e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—NCOR1—malignant glioma	3.91e-05	9.83e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.9e-05	9.82e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CB—malignant glioma	3.9e-05	9.8e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CD—malignant glioma	3.88e-05	9.77e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.88e-05	9.77e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTP1—malignant glioma	3.87e-05	9.72e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTGS2—malignant glioma	3.86e-05	9.71e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP2C18—malignant glioma	3.83e-05	9.64e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTT1—malignant glioma	3.81e-05	9.58e-05	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AKT1—malignant glioma	3.79e-05	9.54e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.79e-05	9.53e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTT1—malignant glioma	3.79e-05	9.53e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTEN—malignant glioma	3.78e-05	9.51e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP2B6—malignant glioma	3.78e-05	9.5e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CAT—malignant glioma	3.76e-05	9.46e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MYC—malignant glioma	3.75e-05	9.44e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—AKT1—malignant glioma	3.73e-05	9.37e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CD—malignant glioma	3.7e-05	9.31e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—EGFR—malignant glioma	3.67e-05	9.23e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CA—malignant glioma	3.66e-05	9.2e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.61e-05	9.09e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS1—malignant glioma	3.57e-05	8.98e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.56e-05	8.95e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—NCOR1—malignant glioma	3.55e-05	8.93e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS1—malignant glioma	3.55e-05	8.93e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.54e-05	8.89e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—RAF1—malignant glioma	3.47e-05	8.72e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KRAS—malignant glioma	3.47e-05	8.72e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—IDH1—malignant glioma	3.46e-05	8.69e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CB—malignant glioma	3.39e-05	8.52e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTEN—malignant glioma	3.37e-05	8.47e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SPHK1—malignant glioma	3.34e-05	8.41e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—BCHE—malignant glioma	3.32e-05	8.35e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—BCHE—malignant glioma	3.3e-05	8.3e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.29e-05	8.28e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC5A5—malignant glioma	3.28e-05	8.24e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP2C18—malignant glioma	3.28e-05	8.24e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	3.27e-05	8.23e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC5A5—malignant glioma	3.26e-05	8.2e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CB—malignant glioma	3.23e-05	8.12e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTGS2—malignant glioma	3.2e-05	8.04e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CAV1—malignant glioma	3.19e-05	8.02e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CA—malignant glioma	3.19e-05	8.01e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.18e-05	7.99e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IL2—malignant glioma	3.11e-05	7.82e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTT1—malignant glioma	3.1e-05	7.8e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.1e-05	7.8e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.09e-05	7.77e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.08e-05	7.75e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.07e-05	7.73e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CA—malignant glioma	3.06e-05	7.71e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.05e-05	7.68e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	3e-05	7.55e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—malignant glioma	2.99e-05	7.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS1—malignant glioma	2.91e-05	7.31e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CG—malignant glioma	2.9e-05	7.3e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CAV1—malignant glioma	2.9e-05	7.28e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.89e-05	7.28e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.81e-05	7.08e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PPARG—malignant glioma	2.8e-05	7.05e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTEN—malignant glioma	2.79e-05	7.01e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.72e-05	6.83e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—BCHE—malignant glioma	2.7e-05	6.79e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.68e-05	6.74e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CA—malignant glioma	2.67e-05	6.71e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.67e-05	6.71e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.66e-05	6.7e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTT1—malignant glioma	2.65e-05	6.66e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—malignant glioma	2.64e-05	6.65e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTP1—malignant glioma	2.64e-05	6.64e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CG—malignant glioma	2.64e-05	6.63e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTP1—malignant glioma	2.63e-05	6.6e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—malignant glioma	2.6e-05	6.55e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CAT—malignant glioma	2.57e-05	6.46e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CAT—malignant glioma	2.55e-05	6.43e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CD—malignant glioma	2.55e-05	6.42e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PPARG—malignant glioma	2.55e-05	6.4e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.52e-05	6.35e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—malignant glioma	2.5e-05	6.3e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.5e-05	6.29e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS1—malignant glioma	2.48e-05	6.24e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.47e-05	6.22e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NCOR1—malignant glioma	2.43e-05	6.1e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NCOR1—malignant glioma	2.41e-05	6.07e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CA—malignant glioma	2.38e-05	5.98e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CD—malignant glioma	2.32e-05	5.83e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—BCHE—malignant glioma	2.31e-05	5.81e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.28e-05	5.73e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—malignant glioma	2.25e-05	5.65e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CB—malignant glioma	2.22e-05	5.6e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS2—malignant glioma	2.2e-05	5.54e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.18e-05	5.48e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—malignant glioma	2.18e-05	5.48e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.16e-05	5.42e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTP1—malignant glioma	2.15e-05	5.41e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.14e-05	5.37e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CAT—malignant glioma	2.09e-05	5.26e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CA—malignant glioma	2.06e-05	5.19e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CB—malignant glioma	2.02e-05	5.08e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS2—malignant glioma	2e-05	5.04e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—malignant glioma	2e-05	5.02e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CAV1—malignant glioma	1.98e-05	4.98e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NCOR1—malignant glioma	1.97e-05	4.97e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CA—malignant glioma	1.97e-05	4.95e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CAV1—malignant glioma	1.97e-05	4.95e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—malignant glioma	1.94e-05	4.88e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTEN—malignant glioma	1.92e-05	4.84e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.89e-05	4.75e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.88e-05	4.73e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.86e-05	4.69e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTP1—malignant glioma	1.84e-05	4.62e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.8e-05	4.53e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CG—malignant glioma	1.79e-05	4.51e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CAT—malignant glioma	1.79e-05	4.49e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTEN—malignant glioma	1.75e-05	4.39e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PPARG—malignant glioma	1.74e-05	4.37e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PPARG—malignant glioma	1.73e-05	4.35e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NCOR1—malignant glioma	1.69e-05	4.24e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—malignant glioma	1.69e-05	4.24e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CAV1—malignant glioma	1.61e-05	4.05e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—malignant glioma	1.61e-05	4.04e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CD—malignant glioma	1.58e-05	3.98e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CD—malignant glioma	1.57e-05	3.96e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.54e-05	3.87e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.47e-05	3.69e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPARG—malignant glioma	1.42e-05	3.56e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.38e-05	3.47e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CAV1—malignant glioma	1.38e-05	3.46e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CB—malignant glioma	1.37e-05	3.45e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS2—malignant glioma	1.37e-05	3.44e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS2—malignant glioma	1.36e-05	3.42e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CA—malignant glioma	1.36e-05	3.41e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.31e-05	3.31e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.29e-05	3.24e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.25e-05	3.15e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CA—malignant glioma	1.23e-05	3.1e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPARG—malignant glioma	1.21e-05	3.04e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTEN—malignant glioma	1.19e-05	3e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTEN—malignant glioma	1.19e-05	2.98e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.12e-05	2.83e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS2—malignant glioma	1.11e-05	2.8e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—malignant glioma	1.11e-05	2.79e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.1e-05	2.77e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—malignant glioma	1.01e-05	2.53e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTEN—malignant glioma	9.71e-06	2.44e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CB—malignant glioma	9.6e-06	2.42e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS2—malignant glioma	9.51e-06	2.39e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CA—malignant glioma	8.42e-06	2.12e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CA—malignant glioma	8.37e-06	2.1e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTEN—malignant glioma	8.3e-06	2.09e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—malignant glioma	6.87e-06	1.73e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CA—malignant glioma	6.85e-06	1.72e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—malignant glioma	6.84e-06	1.72e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CA—malignant glioma	5.85e-06	1.47e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—malignant glioma	5.6e-06	1.41e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—malignant glioma	4.78e-06	1.2e-05	CbGpPWpGaD
